Skip to main content
SpringerLink
Log in

Neue Wege in der Therapie der Osteoporose

  • Chapter
Gesundheit

Part of the book series: Heidelberger Jahrbücher ((HJB,volume 50))

  • 1299 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Albright F, Burnett CH, Cope O, Parson W (1941) Acute atrophy of bone (osteoporosis) simulating hyperparathyroidism. J Clin Endocrin 9:711–716

    Google Scholar 

  • Appelboom T, Body J-J (1993) The antiquity of osteoporosis: more questions than answers. Calcif Tissue Int 53:367–369

    PubMed  CAS  Google Scholar 

  • Arzneimittelkommission der Deutschen Ärzteschaft (2003) Empfehlungen zur Therapie und Prophylaxe der Osteoporose. 1. Auflage (2. Auflage 2005 in Vorbereitung). Arzneiverordnung in der Praxis 30 (Sonderheft):1–30

    Google Scholar 

  • Arras D, Ziegler R, Sommer U, Multerer A, Nawroth P, Kasperk C (2004) Knochendichteveränderung unter Fluoridtherapie der Osteoporose in Abhängigkeit von Fluoriddosis, Fluoridpräparat und Geschlecht. Osteologie 13:31–41

    Article  Google Scholar 

  • Barnett E, Nordin BEC (1960) The radiological diagnosis of osteoporosis: a new approach. Cin Radiol 11:166–174

    Article  CAS  Google Scholar 

  • Baron R (2003) General principles of bone biology. In: Favus M (ed.) Primer on the metabolic bone diseases and disorders ofmineral metabolism. American Society for Bone andMineral Research, Kelseyville/CA, 1–8

    Google Scholar 

  • Berson SA, Yalow RS (1968) Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocrinol Metab 28:1037–1047

    PubMed  CAS  Google Scholar 

  • Berson SA, Yalow RS, Bauman A, Rothschild MA, Nuverly K (1956) Insulin-I 131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. J Clin Invest 35:170–190

    PubMed  CAS  Google Scholar 

  • Blunt JW, DeLuca HF, Schnoes HK (1968) 25-Hydroxycholecalciferol: a biologically active metabolite of vitamin D 3. Biochemistry 7:3317–3322

    Article  PubMed  CAS  Google Scholar 

  • Browner W, Seeley D, Vogt T (1991) Non-trauma-mortality in elderly women with low bone mineral density. Lancet 338:355–358

    Article  PubMed  CAS  Google Scholar 

  • Browner W, Pressman A, Nevitt M (1993) Association between low bone density and stroke in elderly women. Stroke 24:940–946

    PubMed  CAS  Google Scholar 

  • Burger H, de Laet CEDH, Weel AEAM et al. (1999) Added value of bone mineral density in hip fracture risk scores. Bone 25:369–374

    Article  PubMed  CAS  Google Scholar 

  • Cameron JR, Sorensen JA (1963) Measurement of bone mineral in vivo: an improved method. Science 142:230–232

    Article  PubMed  CAS  Google Scholar 

  • Cappuccio F, Meilahn E, Zmuda J (1999) High blood pressure and bone mineral loss in elderly women. Lancet 354:971–975

    Article  PubMed  CAS  Google Scholar 

  • Center J, Nguyen T, Schneider D, Sambrook P, Eisman J (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878–882

    Article  PubMed  CAS  Google Scholar 

  • Chan K, Andrade S, Boles M (2000) Inhibitors of HMG-CoAReductase and the risk of fracture among older women. Lancet 355:2185–2188

    Article  PubMed  CAS  Google Scholar 

  • Chesnut CH, Silverman S, Andriano K et al. for the PROOF Study Group (2000) A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 109:267–276

    Article  PubMed  CAS  Google Scholar 

  • Civitelli R, Gonnelli S, Zacchei F et al. (1988) Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 82:1268–1274

    PubMed  CAS  Google Scholar 

  • Compston JE, Cooper C, Kanis JA (1995) Bone densitometry in clinical practice. Brit Med J 310:1507–1510

    PubMed  CAS  Google Scholar 

  • Copp DH, Cameron EC, Cheney B et al. (1962) Evidence for calcitonin — a new hormone from the parathyroid that lowers blood calcium. Endocrinology 70:638–649

    PubMed  CAS  Google Scholar 

  • Delling G (1975) Endokrine Osteopathien. Stuttgart: Gustav Fischer, 1–111

    Google Scholar 

  • Doherty T, Detrano R (1994) Coronary arterial calcification as an active process: a new perspective on an old problem. Calcif Tissue Int 54:224–230

    Article  PubMed  CAS  Google Scholar 

  • Donahue S, Sharkey N, Modamlou K, Sequeira L, Martin R (2000) Bone strain and microcracks at stress fracture sites in human metzatarsals. Bone 27:827–833

    Article  PubMed  CAS  Google Scholar 

  • Edwards C, Hart D, Spector T (2000) Oral statins and increased bone mineral density in postmenopausal women. Lancet 355:2218–2219

    Article  PubMed  CAS  Google Scholar 

  • EPOS (European Prospective Osteoporosis Study group) (2002) Incidence of vertebral fracture in Europe: results from the European prospective osteoporosis study (EPOS). J Bone Min Res 17:716–724

    Article  Google Scholar 

  • Ettinger B, Black D, Nevitt M, Rundle A, Cauley J, Cummings S, Genant H (1992) Contribution of vertebral deformities to chronic back pain and disability. J Bone Min Res 7:449–456

    CAS  Google Scholar 

  • Ettinger B, Black DM, Mitlak BH et al. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial. JAMA 282:637–645

    Article  PubMed  CAS  Google Scholar 

  • Fletcher S, Colditz G (2002) Failure of estrogen plus progestin therapy for prevention. JAMA 288:366–367 and 321–333

    Article  PubMed  Google Scholar 

  • Frost H (1991) Anew direction for osteoporosis research: a review and proposal. Bone 12: 429–437

    Article  PubMed  CAS  Google Scholar 

  • Fuller K, Wong B, Fox S, Choi Y, Chambers TJ (1998) TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188:997–1001

    Article  PubMed  CAS  Google Scholar 

  • Gordan GS, Picchi J, Roof BS (1973) Antfracture efficacy of long-termestrogens for osteoporosis. Trans Ass Amer Physicians 86:326–332

    PubMed  CAS  Google Scholar 

  • Grady D, Herrington D, Bittner V (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow up (HERS II). JAMA 288:49–57

    Article  PubMed  Google Scholar 

  • Hak A, Pohls H, Van Hemert A (2000) Progression of aortic calcification is associated with metacarpal bone loss during menopause. Arterioscler Thromb Vasc Biol 20:1926–1931

    PubMed  CAS  Google Scholar 

  • Hofbauer LC, Khosla S, Dunstan CR et al. (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2–12

    Article  PubMed  CAS  Google Scholar 

  • Holick MF, Schnoes HK, DeLuca HF et al. (1971) Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry 10:2799–2804

    Article  PubMed  CAS  Google Scholar 

  • Jalava T, Sarna S, Pylkkänen Liisa, Mawer B, Kanis J, Selby P, Davies M, Adams J, Francis R, Robinson J, McCloskey E (2003) Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Min Res 18:1254–1260

    Article  Google Scholar 

  • Jono S, Nishizawa Y, Shioi A, Morii H (1997) Parathyroid hormone related peptide as a local regulator of vascular calcification: its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:1135–1142

    PubMed  CAS  Google Scholar 

  • Kasperk C, Wergedal J, Farley J, Linkhart T, Turner R, Baylink D (1989) Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124:1576–1578

    Article  PubMed  CAS  Google Scholar 

  • Kasperk C, Ziegler R (1992) Androgens and bone metabolism. Significance in osteoporosis in men and women. Dtsch Med Wschr 117:990–996

    Article  PubMed  CAS  Google Scholar 

  • Kasperk C, Wergedal J, Strong D, Farley J, Wangerin K, Gropp H, Ziegler R, Baylink D (1995) Human bone cell phenotypes differ depending on their skeletal site of origin. J Clin Endocrinol Metab 80:2511–2517

    Article  PubMed  CAS  Google Scholar 

  • Kasperk C, Fehling K, Borcsok I, Ziegler R (1996) Effects of androgens on subpopulations of the human osteosarcoma cell line SaOS2. Calcif Tissue Int 58:376–382

    PubMed  CAS  Google Scholar 

  • Kasperk C, Helmboldt A, Borcsok I, Heuthe S, Cloos O, Niethard F, Ziegler R (1997a) Skeletal site dependent expression of the androgen receptor in human osteoblastic cell populations. Calcif Tissue Int 61:464–473

    Article  PubMed  CAS  Google Scholar 

  • Kasperk C, Wakley G, Hierl T, Ziegler R (1997b) Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro. J Bone Min Res 12:464–471

    Article  CAS  Google Scholar 

  • Kasperk C (2002) New therapy for painful vertebral fractures: filling with cement instead of analgesics. MMW Fortschr Med 144:12–15

    PubMed  CAS  Google Scholar 

  • Kasperk C, Hillmeier J, Nöldge G et al. (2003) Kyphoplastie — Konzept zur Behandlung schmerzhafter Wirbelkörperbrüche. Dtsch Ärzteblatt 100:C 1363–1366

    Google Scholar 

  • Kasperk C, Hillmeier J, Nöldge G, Grafe I, DaFonseca K, Raupp D, Bardenheuer H, Libicher M, Liegibel U, Sommer U, Hilscher U, Pyerin W, Vetter M, Meinzer H, Meeder P, Nawroth P (2005) Tretament of painful vertebral fractures by kyphoplasty in patients with primary osteoporosis: a prospective nonrandomized controlled study. J Bone Min Res 20:604–612

    Article  Google Scholar 

  • Li Y, Kong J, Wie M (2002) 1,25 dihydroxyvitamin D3 is a negative endocrine regulator of the renin angiotemsin system. J Clin Invest 110:229–238

    Article  PubMed  CAS  Google Scholar 

  • Liegibel U, Sommer U, Tomakidi P, Hilscher U, vandenHeuvel L, Pirzer R, Hillmeier J, Nawroth P, Kasperk C (2002) Concerted action of androgens and mechanical strain shifts bone metabolism from high turnover into an osteoanabolic mode. J Exp Med 196:1387–1392

    Article  PubMed  CAS  Google Scholar 

  • Liegibel U, Sommer U, Bundschuh B, Schweizer B, Hilscher U, Lieder A, Nawroth P, Kasperk C (2004) Fluid shear of low magnitude increases growth and expression of TGFß1 and adhesion molecules in human bone cells in vitro. Exp Clin Endocrinol Diabetes 112:356–363

    Article  PubMed  CAS  Google Scholar 

  • Lilliu H, Pamphile R, Chapuy MC et al. (2003) Calcium-vitamin D 3 supplementation is costeffective in hip fractures prevention. Maturitas 44:299–305

    Article  PubMed  CAS  Google Scholar 

  • Luo G, Ducy P, McKee M (1997) Spontaneous calcification of arteries and cartilage in mice lacking matric GLA protein. Nature 386:78–81

    Article  PubMed  CAS  Google Scholar 

  • Mehl B, Delling G, Schlindwein I et al. (2002) Korrelieren Knochenstoffwechselmarkermit einer histologisch gesicherten High-bzw. Low-Turnover-Osteoporose? Med Klein 97:588–594

    Article  CAS  Google Scholar 

  • Meier DE, Luckey MM, Wallenstein S et al. (1992) Racial differences in pre-and postmenopausal bone homeostasis: association with bone density. J Bone Miner Res 7: 1181–1189

    PubMed  CAS  Google Scholar 

  • Meier C, Schlienger R, Kraenzlin M (2000) HMG-CoAReductase inhibitors and the risk of fractures. JAMA 283:3205–3210

    Article  PubMed  CAS  Google Scholar 

  • Meunier PJ, Roux C, Seeman E et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–486

    Article  PubMed  CAS  Google Scholar 

  • Meyer G, Warnke A, Bender R, Mühlhauser I (2003) Effect on hip fractures of increased use of hip protectors in nursing homes: cluster randomised controlled trial. Brit Med J 326:76–81

    Article  PubMed  Google Scholar 

  • Minne HW, Leidig G, Wüster C et al. (1988) A newly developed spinal deformity index (SDI) to quantitate v ertebral crush fractures in patients with osteoporosis. Bone Miner 3:335–349

    PubMed  CAS  Google Scholar 

  • Morrison NA, Qi JC, Tokita A et al. (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367: 284–287

    Article  PubMed  CAS  Google Scholar 

  • Munroe P, Olgunturk R, Fryns J (1999) Mutations in the gene encoding the human matrix GLA protein cause Keutel syndrome. Nat Genetics 21:142–144

    Article  CAS  Google Scholar 

  • Nawroth P, Pirzer R, Fohr B, Schilling T, Ziegler R, Bierhaus A, Kasperk C (2003) Osteoporose und koronare Herzkrankheit — zwei Seiten der gleichen Münze? Med Klein 98:437–446

    Article  CAS  Google Scholar 

  • Neer RM, Arnaud CZ, Zanchetta JR et al. (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441

    Article  PubMed  CAS  Google Scholar 

  • Nieves J, Formica C, Ruffing J, Zion M, Garrett P, Lindsay R, Cosman F (2005) Males have larger skeletal size and bone mass than females, despite comparable body size. J Bone Min Res 20:529–538

    Article  Google Scholar 

  • Pecile A (ed.) (1980) Calcitonin 1980. ICS Nr 540. Amssterdam: Excerpta Medica

    Google Scholar 

  • Pommer G (1885) Untersuchungen über Osteomalacie und Rachitis. Leipzig: FCWVogel

    Google Scholar 

  • Ralston SH (2002) Genetic susceptibility to osteoporopsis. J Clin Endocrinol Metab 87:2460–2466

    Article  PubMed  CAS  Google Scholar 

  • Ravn P, Hetland M, Overgaard K (1994) Pre-and postmenopausal changes in bone mineral density of the proximal femur measured by dual-energy X-ray absorptiometry. J Bone Min Res 9:1975–1980

    Article  CAS  Google Scholar 

  • Recklinghausen F von (1891) Die fibröse oder deformirende Ostitis, die Osteomalacie und die osteoplastische Carcinose in ihren gegenseitigen Beziehungen. In: Festschrift Rudolf Virchow zu seinem 71. Geburtstage. Berlin: Verlag G Reimer

    Google Scholar 

  • Reeve J, Hesp R, Williams P et al. (1976) Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet 1:1035–1038

    Article  PubMed  CAS  Google Scholar 

  • Reutter FW, Siebenmann R (1965) Die Wirkung von Natriumfluorid bei metabolischen Knochenerkrankungen. Helv Med Acta 32:493–497

    Google Scholar 

  • Rich C, Ensinck J, Ivanovich P (1964) The effects of sodium-fluoride on calcium metabolism of subjects with metabolic bone diseases. J Clin Invest 43:545–552

    Article  PubMed  CAS  Google Scholar 

  • Schäfer A, Ziegler R, Minne H, Delling G (1978) Combined therapy with NaF, calcium and vitamin D in idiopathic osteoporosis. In: Courvoisier B, Donath A, Baud CA (eds.) Fluoride and Bone, II Symp CEMO 1977 Genève: Editions Médecine et Hygiène, 233–237

    Google Scholar 

  • Schaffler M, Choi K, Milgrom C (1995) Aging and matrix microdamage accumulation in human compact bone. Bone 17:521–525

    Article  PubMed  CAS  Google Scholar 

  • Shioi A, Nishizawa Y, Jono S (1995) β-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Throm Vasc Biol 15:2003–2009

    CAS  Google Scholar 

  • Shorr E, Carter AC (1952) The usefulness of strontium as an adjuvant to calcium in the remineralization on skeleton in man. Bull Hosp Jt Dis Orthop Inst 13:59–66

    CAS  Google Scholar 

  • Sirola J, Kröger H, Honkanen R et al. (2003) Factors affecting bone loss around the menopause in women without HRT: a prospective study. Maturitas 45: 159–167

    Article  PubMed  Google Scholar 

  • Suzuki T, Yoshida H, Hashimoto T et al. (1997) Case-control study of risk factors for hip fractures in the Japanese elderly by a mediterranean osteoporosis study (MEDOS) questionnaire. Bone 21:461–467

    Article  PubMed  CAS  Google Scholar 

  • Teitelbaum S (2000) Bone resorption by osteoclasts. Science 289:1504–1508

    Article  PubMed  CAS  Google Scholar 

  • Theill L, Boyle W, Penninger J (2002) RANKL and RANK: T cells, bone loss, and mammalian evolution. Ann Rev Immunol 20:795–823

    Article  CAS  Google Scholar 

  • Turgeon J, McDonnell D, Martin K, Wise P (2004) Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304:1269–1273

    Article  PubMed  CAS  Google Scholar 

  • Van der Schouw Y, van der Graaf Y, Steyerberg E (1996) Age at menopause as a risk factor for cardiovascular mortality. Lancet 347:714–718

    Article  PubMed  Google Scholar 

  • Von der Recke P, Hansen M, Hassager C (1999) The association between low bone mass at the menopausee and cardiovascular mortality. Am J Med 106:273–278

    Article  PubMed  Google Scholar 

  • Wang P, Solomon D, Mogun H (2000) HMG-CoA-Reduktase inhibitors and the risk of hip fractures in elderly patients. JAMA 283:3211–3216

    Article  PubMed  CAS  Google Scholar 

  • World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843, Geneva.

    Google Scholar 

  • Yalow RS (1978) Radioimmunoassay: a probe for the fine structure of biological systems. Science 200:1236–1245

    Article  PubMed  CAS  Google Scholar 

  • Ziegler R (1987) Zur Frage einer allgemeinen undifferenzierten Östrogen-(Progestagen-)Substitution als Osteoporoseprophylaxe: Kontra. Med Klinik 82:241–244

    CAS  Google Scholar 

  • Ziegler R (2002) Osteoporose: aktuelle Diagnostik und Therapie. Orthopädische Praxis 38:570–577

    Google Scholar 

  • Ziegler R, Deutschle U, Raue F (1984) Calcitonin in human pathophysiology. Hormone Res 20:65–73

    Article  PubMed  CAS  Google Scholar 

  • Ziegler R, Scheidt-Nave C, Leidig-Bruckner G (1996) What is a vertebral fracture? Bone 18:169S–177S

    Article  PubMed  CAS  Google Scholar 

  • Zioupos P, Currey J (1998) Changes in the stiffness, strength, and toughness of human cortical bone with age. Bone 22:57–66

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Innere Medizin I, Medizinische Universitätsklinik, Im Neuenheimer Feld 410, 69120, Heidelberg

    Prof. Dr. med. Dr.med. dent. Christian Kasperk, Prof. Dr. med. Dr. h. c. Reinhard Ziegler & Prof. Dr. med. Peter Nawroth

Authors
  1. Prof. Dr. med. Dr.med. dent. Christian Kasperk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Dr. h. c. Reinhard Ziegler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. med. Peter Nawroth
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chirurgische Universitätsklinik, Universität Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg

    Christian Herfarth

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kasperk, C., Ziegler, R., Nawroth, P. (2007). Neue Wege in der Therapie der Osteoporose. In: Herfarth, C. (eds) Gesundheit. Heidelberger Jahrbücher, vol 50. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-48562-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-48562-9_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-48561-2

  • Online ISBN: 978-3-540-48562-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation